BREAKING: The FDA authorizes another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up
— even as vaccination has stalled. About two-thirds of Americans are fully vaccinated, and half of those eligible for a first booster haven’t gotten one.
None of the COVID-19 vaccines are as strong against the omicron mutant as they were against earlier versions of the virus. Also, protection against milder infections naturally wanes over time. But the immune system builds multiple layers of defense and the type that prevents severe illness and death is holding up.During the U.S. omicron wave, two doses were nearly 80% effective against needing a ventilator or death — and a booster pushed that protection to 94%, the CDC recently reported.
“The ‘when’ is a really difficult part. Ideally we would time booster doses right before surges but we don’t always know when that’s going to be,” said Dr. William Moss of the Johns Hopkins Bloomberg School of Public Health.Plus, a longer interval between shots helps the immune system mount a stronger, more cross-reactive defense.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA OKs second Pfizer, Moderna COVID-19 booster for ages 50 and upU.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.
Read more »
FDA Authorizes Fourth Pfizer and Moderna Covid Vaccine Doses for People Age 50 and OlderThe FDA made the decision comes without consulting its committee of independent vaccine experts.
Read more »
Pfizer recalls 3 blood pressure drugs due to cancer riskICYMI: Pfizer is recalling three blood pressure medications over an impurity that could cause cancer.
Read more »
Americans 50 and Up Can Now Get Another COVID BoosterThe question is whether everyone who's eligible should rush out and get it. The Centers for Disease Control and Prevention is expected to weigh in
Read more »
FDA OKs second Pfizer, Moderna COVID-19 booster for ages 50 and upU.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.
Read more »